BeOne Medicines
ONC
#900
Rank
HK$214.99 B
Marketcap
HK$2,072
Share price
1.62%
Change (1 day)
-4.53%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Financial Statements

Thumbnail BeOne Medicines Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement